VIRPAX has licensed a patented aerosol-based system that delivers active pharmaceutical ingredients (API) as a Patch-in-a-Can®. This meter dosed spray delivers the API as a film over a 12 hour period with numerous advantages.
President, American Pain Association
Convenient – no messy cream or gels that can be rubbed off by clothing or physical contact
Aesthetically appealing – invisible once applied
Extended or immediate release formulation can be manipulated to deliver API immediately or over extended times from 12 to 48 hrs
Easily optimizable – film and excipients can be varied according to active and target. Metered dose or continuous delivery valves are available based on patient need
Validated on a wide variety of pharmaceuticals including a clinical trial to show non-inferiority to a leading brand
An alternative to current pain remedies with more efficient delivery and little reservoir of residue drug remaining in formulation
On application, the formulation has cooling/relieving attributes which appeal to the patient for many applications e.g. to counter itching and burning sensations
Potential to demonstrate enhanced drug delivery to or across the skin or buccal mucosa
Charles Argoff, M.D.
Target market: Topical treatment of acute pain using NSAIDS
Target market: Topical treatment of acute pain using NSAIDS delay, decrease, and/or eliminate the potential need for opioids during post-surgical recovery